InvestorsHub Logo
Followers 30
Posts 5100
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Thursday, 02/25/2021 2:16:44 PM

Thursday, February 25, 2021 2:16:44 PM

Post# of 429484
A number of serious posters here on iHub AMRN have since New year 2021 - pointed out the fact that Amarin and Vascepa is in a Great Position - despite the Nevada Ruling marts 2020.

Confirmed here from today:

https://www.fool.com/investing/2021/02/25/how-amarin-beat-wall-streets-q4-estimates/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
------------------------------

How things will progress from here' - there's two', some would say three' possibilities.

I personally, at this point, don't believe in a BO in 2021 - so that leaves two different roads of progress:

1. The Long and Winding Road - of GIA in Europe China later in the year - you would expect SP slowly picking up - to somewhere in the early teens.

2. The Reason for this post - this is where the excitement really is for AMRN shareholders in 2021. The two (3) litigation cases.

It's aloud to dream that Judge Du - will 'once again chock Bio World' and reverse the Patent ruling - reinstating Patents as originally granted. If the case from 'iHub rule 60 team' - will prove that 'reversal' is the right juristical and moral thing to do' I truly believe the Judge will do that.

And then there is the Infringement case from Amarin - also very' very' exciting to follow in light of how GSK Teva case ends.
-------------------

Any of these cases a Homerun - SP will go seriously North :)



Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News